Skip to Content

The Week Ahead: CVS and Berkshire Hathaway to Report Earnings

We also anticipate an earnings report from Uber.

Mentioned: , , ,

Correction: An earlier version of this article stated that Uber was set to report earnings on Nov. 1 and CVS and Berkshire Hathaway were set to report earnings Nov. 2. Their reporting dates have since moved to Nov. 5 and Nov. 6. 

Earnings season is winding down, and we only expect three big companies to report in the week ahead. We are prepared to hear from Uber Technologies
(UBER) on Thursday, followed by CVS Health (CVS) and Berkshire Hathaway (BRK.B) on Friday.  

With drivers completing trips over billions of miles and 111 million users using its food delivery service at least once a month, Uber is the largest on-demand ride-sharing provider in the world (outside of China). However, the firm, which has a Morningstar Economic Moat Rating of narrow, faces tough competition in the United States with Lyft
(LYFT). After a 75% year-over-year decline in rides in April, ride demand has slowly improved, and we expect gradual improvement in the third and fourth quarters.  

Between the death of Justice Ruth Bader Ginsburg on Sept. 18 and the upcoming election, there are several layers of complexity surrounding the healthcare industry. On Nov. 10, a week after the U.S. election, the Supreme Court is scheduled to hear oral arguments on the Affordable Care Act. There are various scenarios that could affect the U.S. healthcare system--and companies in the healthcare industry such as CVS. 

Like every company and industry, Berkshire Hathaway is not immune to the coronavirus. However, we do think the wide-moat firm offers potential downside protection in a downturn for its subsidiaries. Berkshire Hathaway is a broadly diversified conglomerate, and we expect the company to continue to grow book value per share at a high-single-digit rate on average during most years despite the pandemic’s negative impacts.  

Carole Hodorowicz does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.